Announced
Completed
Financials
Sources
Tags
Private
Cross Border
Venture Capital
inflammatory airway diseases treatment
Iceland
Minority
Biotechnology
Acquisition
Completed
Friendly
Single Bidder
Synopsis
Investors Flerie Invest and Kvika led the $23m round in EpiEndo Pharmaceuticals. New and existing investors that also participated include European Innovation Council and ABC Ventures. “We have followed EpiEndo for some time and have seen impressive progress towards clinical phase of their lead compound EP 395. We are proud to take part in their continuing journey with the aim to deliver substantially improved treatment of COPD,” Carl-Johan Spak, Flerie Invest Senior Advisor.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.